On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, to develop the SCoV-2 Detect IgM/IgG Rapid Test, a point-of-care test for detection of SCoV-2 specific IgM/IgG antibodies.